全球青光眼手術設備市場（2024年）：2023年至2029年分析

本報告調查了全球青光眼手術器械市場，重點介紹了微支架、結膜下分流器、管手術器械和管分流器的產品類別，提供未來五年的市場表現和主要趨勢預測，未來重要趨勢 ，以及進入市場的22 家公司的公司簡介。也調查青光眼手術中使用的雷射。

目錄

• 有關青光眼、青光眼人口和青光眼診斷的背景信息
• 青光眼設備目前的銷售預測，包括平均價格和總收入
• 潛在設備買家概況，包括眼科醫師、眼科專家、驗光師及一般醫生
• 有關製造商的信息
• 當前償付率

What's New:

The new "2024 Glaucoma Surgical Device Market Report" provides an in-depth look at a record 18 early-stage glaucoma device and laser companies. Iantrek, led by one of ophthalmology's most prolific innovators, is preparing to launch several revolutionary glaucoma treatments, including the AlloFlo, the first biotissue stent.

Several promising new subconjunctival products are also examined. These include Avisi Technologies' ultrathin filtration plate implant, Myra Vision's adjustable post-op shunt, and Ciliatech's uveoscleral filtration acrylic plate.

The report also highlights emerging laser technologies that have the potential to dramatically expand the use of lasers in glaucoma, such as the Belkin DSLT laser, ViaLase femtosecond laser, Elios ELT laser, and IOPtimate CO2 laser.

In addition, the report tracks advancements in sustained drug delivery devices, providing insights into ongoing progress in this field.

The "2024 Glaucoma Surgical Device Market Report" offers a comprehensive analysis of the current global market for glaucoma devices, as well as a discussion of important trends, an examination of upcoming products that will impact the market, and a review of other key factors shaping future success.

The report analyzes the prevalence of glaucoma worldwide and discusses the ophthalmologists who treat glaucoma. It also examines the role of surgical intervention, the market dynamics for currently commercialized products, and the pipeline of investigational devices that may offer improved outcomes.

Product demand is forecast in units and dollars, and market shares are analyzed by product category. Twenty-two market competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

Contents:

The report focuses on the product categories of microstents, formerly referred to as minimally invasive glaucoma surgery (MIGS) devices; subconjunctival shunts; canal surgery devices; and tube shunts. It also examines lasers used in glaucoma procedures. Each segment provides an analysis of market competitors and five-year market forecasts for units and dollars.

Also included in the report:

• Background information about glaucoma, glaucoma populations, and glaucoma diagnosis.
• Estimates of current sales and sales forecasts for glaucoma devices, including average prices and total revenue.
• Profiles of prospective device buyers, including ophthalmologists, ophthalmic specialists, optometrists, and general medical doctors.
• Information about manufacturers.
• Current reimbursement rates.